Population pharmacokinetic modelling of darifenacin and its hydroxylated metabolite using pooled data, incorporating saturable first‐pass metabolism, CYP2D6 genotype and formulation‐dependent bioavailability (Q30884154)
Jump to navigation
Jump to search
scientific article published on December 1, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Population pharmacokinetic modelling of darifenacin and its hydroxylated metabolite using pooled data, incorporating saturable first‐pass metabolism, CYP2D6 genotype and formulation‐dependent bioavailability |
scientific article published on December 1, 2003 |
Statements
1 reference
Population pharmacokinetic modelling of darifenacin and its hydroxylated metabolite using pooled data, incorporating saturable first-pass metabolism, CYP2D6 genotype and formulation-dependent bioavailability (English)
1 reference
Population pharmacokinetic modelling of darifenacin and its hydroxylated metabolite using pooled data, incorporating saturable first‐pass metabolism, CYP2D6 genotype and formulation‐dependent bioavailability (English)
Thomas Kerbusch
1 reference
Ulrika Wählby
1 reference
1 December 2003
1 reference
1 reference
639-652
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference